The China Pompe Disease Treatment Market is observing a notable rise in treatment volume, projected to reach USD 113.82 million by 2035. This surge reflects a compound annual growth rate (CAGR) of 4.38%, driven by a growing awareness of Pompe disease and advancements in therapeutic options. The increasing diagnosis rates coupled with advancements in enzyme replacement therapies are key...